TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGANTS USING GENETICALLY MODIFIED LACTOBACILLUS
- 专利权人:
- ACTOGENIX N.V.
- 发明人:
- ROTTIERS, PIETER,SNOECK, VEERLE
- 申请号：
- DK08708224
- 公开号：
- DK2125010T3
- 申请日:
- 2008.01.25
- 申请国别(地区):
- DK
- 年份:
- 2014
- 代理人:
- 摘要：
- The present invention relates to the treatment of allergy by mucosal delivery by microorganism, in particular Lactococcus lactis, of secreted antigens involved in the induction of allergy.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- TREATMENT OF IMMUNE DISEASE BY MUCOSAL ADMINISTRATION OF ANTIGENS
- TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENS
- Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus
- WiKim0107 Enterococcus lactis Wikim0107 strain controlling immune function and ameliorating inflammatory bowel disease and use thereof
- Lactococcus lactis strains for use in improving digestive condition
